3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Withdrawn
1
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neoplasms
6
Lung Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Mycosis Fungoides
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Barrett Esophagus
1
Interventions
Magnetic Resonance Spectroscopy
51
Specimen Handling
42
enzalutamide
36
Androgen Antagonists
35
Radiosurgery
33
Radiotherapy
31
darolutamide
26
Prednisone
26
Abiraterone Acetate
25
Leuprolide
22
Docetaxel
22
apalutamide
21
abiraterone
19
Pluvicto
19
Standard of Care
18
Triptorelin Pamoate
17
Radiation
17
Biopsy
16
relugolix
15
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
15
Goserelin
14
Blood Specimen Collection
13
gallium 68 PSMA-11
12
X-Rays
11
Surveys and Questionnaires
11
pembrolizumab
10
luprolide acetate gel depot
10
Carboplatin
10
Methods
9
Interviews as Topic
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Neoplasms
×
Hematologic Tests
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled